129 related articles for article (PubMed ID: 15312802)
1. The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Delta9-tetrahydrocannabinol.
Verty AN; McGregor IS; Mallet PE
Brain Res; 2004 Sep; 1020(1-2):188-95. PubMed ID: 15312802
[TBL] [Abstract][Full Text] [Related]
2. Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors.
Pisanu A; Acquas E; Fenu S; Di Chiara G
Neuropharmacology; 2006 May; 50(6):661-70. PubMed ID: 16427098
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic system does not play a major role in the precipitated cannabinoid withdrawal syndrome.
Sañudo-Peña MC; Force M; Tsou K; McLemore G; Roberts L; Walker JM
Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1121-4. PubMed ID: 11216447
[TBL] [Abstract][Full Text] [Related]
4. Histaminergic receptors of medial septum and conditioned place preference: D1 dopamine receptor mechanism.
Zarrindast MR; Moghimi M; Rostami P; Rezayof A
Brain Res; 2006 Sep; 1109(1):108-16. PubMed ID: 16828718
[TBL] [Abstract][Full Text] [Related]
5. Regulation of DARPP-32 phosphorylation by Delta9-tetrahydrocannabinol.
Borgkvist A; Marcellino D; Fuxe K; Greengard P; Fisone G
Neuropharmacology; 2008 Jan; 54(1):31-5. PubMed ID: 17686497
[TBL] [Abstract][Full Text] [Related]
6. Acute delta9-tetrahydrocannabinol exposure facilitates quinpirole-induced hyperlocomotion.
Gorriti MA; Ferrer B; del Arco I; Bermúdez-Silva FJ; de Diego Y; Fernandez-Espejo E; Navarro M; Rodríguez de Fonseca F
Pharmacol Biochem Behav; 2005 May; 81(1):71-7. PubMed ID: 15894066
[TBL] [Abstract][Full Text] [Related]
7. Involvement of adenosine A2A and dopamine receptors in the locomotor and sensitizing effects of cocaine.
Filip M; Frankowska M; Zaniewska M; Przegaliński E; Muller CE; Agnati L; Franco R; Roberts DC; Fuxe K
Brain Res; 2006 Mar; 1077(1):67-80. PubMed ID: 16516871
[TBL] [Abstract][Full Text] [Related]
8. Clozapine and SCH 23390 prevent the spatial working memory disruption induced by Δ9-THC administration into the medial prefrontal cortex.
Rodrigues LC; Conti CL; Nakamura-Palacios EM
Brain Res; 2011 Mar; 1382():230-7. PubMed ID: 21281616
[TBL] [Abstract][Full Text] [Related]
9. Baclofen, raclopride, and naltrexone differentially affect intake of fat and sucrose under limited access conditions.
Corwin RL; Wojnicki FH
Behav Pharmacol; 2009 Sep; 20(5-6):537-48. PubMed ID: 19724193
[TBL] [Abstract][Full Text] [Related]
10. Conditioned locomotion induced by unilateral intrastriatal administration of apomorphine: D(2) receptor activation is critical but not the expression of the unconditioned response.
Dias FR; Carey RJ; Carrera MP
Brain Res; 2006 Apr; 1083(1):85-95. PubMed ID: 16530737
[TBL] [Abstract][Full Text] [Related]
11. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake.
Abbott CR; Small CJ; Kennedy AR; Neary NM; Sajedi A; Ghatei MA; Bloom SR
Brain Res; 2005 May; 1043(1-2):139-44. PubMed ID: 15862527
[TBL] [Abstract][Full Text] [Related]
12. Involvement of dopamine receptors in the anti-immobility effects of dopamine re-uptake inhibitors in the forced swimming test.
Yamada J; Sugimoto Y; Yamada S
Eur J Pharmacol; 2004 Nov; 504(3):207-11. PubMed ID: 15541423
[TBL] [Abstract][Full Text] [Related]
13. Effect of the dopamine D1-like receptor antagonist SCH 23390 on the microstructure of ingestive behaviour in water-deprived rats licking for water and NaCl solutions.
Galistu A; D'Aquila PS
Physiol Behav; 2012 Jan; 105(2):230-3. PubMed ID: 21864553
[TBL] [Abstract][Full Text] [Related]
14. Acute neurobehavioral effects of toluene: involvement of dopamine and NMDA receptors.
Lo PS; Wu CY; Sue HZ; Chen HH
Toxicology; 2009 Nov; 265(1-2):34-40. PubMed ID: 19765629
[TBL] [Abstract][Full Text] [Related]
15. Acute and subchronic influences of tetrahydrocannabinols on water and food intake, body weight, and temperature in rats.
Johansson JO; Jarbe TU; Henriksson BG
TIT J Life Sci; 1975; 5(1-2):17-27. PubMed ID: 1188935
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic activity estimation of cannabinoid CB1 receptor ligands in a drug discrimination paradigm.
De Vry J; Jentzsch KR
Behav Pharmacol; 2003 Sep; 14(5-6):471-6. PubMed ID: 14501260
[TBL] [Abstract][Full Text] [Related]
17. Repeated exposure to Delta(9)-tetrahydrocannabinol alters heroin-induced locomotor sensitisation and Fos-immunoreactivity.
Singh ME; McGregor IS; Mallet PE
Neuropharmacology; 2005 Dec; 49(8):1189-200. PubMed ID: 16137723
[TBL] [Abstract][Full Text] [Related]
18. Evidence for an interaction between CB1 cannabinoid and oxytocin receptors in food and water intake.
Verty AN; McFarlane JR; McGregor IS; Mallet PE
Neuropharmacology; 2004 Sep; 47(4):593-603. PubMed ID: 15380376
[TBL] [Abstract][Full Text] [Related]
19. Dopamine-dependent and dopamine-independent actions of cocaine as revealed by brain thermorecording in freely moving rats.
Kiyatkin EA; Brown PL
Eur J Neurosci; 2005 Aug; 22(4):930-8. PubMed ID: 16115216
[TBL] [Abstract][Full Text] [Related]
20. Differential role of dopamine in drug- and lithium-conditioned saccharin avoidance.
Fenu S; Rivas E; Di Chiara G
Physiol Behav; 2005 May; 85(1):37-43. PubMed ID: 15924904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
